BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17250421)

  • 1. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic and biopsy findings leading to conization in adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Obstet Gynecol; 2002 Aug; 100(2):271-6. PubMed ID: 12151149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing visual inspection with acetic acid plus random cervical biopsy plus endocervical curettage to colposcopic directed biopsy plus endocervical curettage in detecting cervical lesions in low-resource settings.
    Puntachai P; Darojn D; Chumworathayi B; Chaousriku W
    Asian Pac J Cancer Prev; 2011; 12(10):2665-8. PubMed ID: 22320971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological significance of atypical glandular cell on Pap smear.
    Behtash N; Nazari Z; Fakhrejahani F; Khafaf A; Azar EG
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):46-9. PubMed ID: 17261100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytology and curetting diagnosis of endocervical adenocarcinoma.
    Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
    J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
    Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
    Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix.
    Srisomboon S; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):377-382. PubMed ID: 30803195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic conization of the cervix: review of 460 consecutive cases.
    Killackey MA; Jones WB; Lewis JL
    Obstet Gynecol; 1986 Jun; 67(6):766-70. PubMed ID: 3703403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colposcopic endocervical brushing cytology appears to be more sensitive than histologic endocervical curettage for detecting endocervical adenocarcinoma.
    Zou T; Dave S; Adler RN; Manning MJ; Scott MP; Strock C; Kandil D; Cosar E; Fischer AH
    J Am Soc Cytopathol; 2021; 10(2):135-140. PubMed ID: 33097463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical endocervical glandular cells: accuracy of cytologic diagnosis.
    Lee KR; Manna EA; St John T
    Diagn Cytopathol; 1995 Oct; 13(3):202-8. PubMed ID: 8575278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ThinPrep Pap Test. Accuracy for glandular disease.
    Ashfaq R; Gibbons D; Vela C; Saboorian MH; Iliya F
    Acta Cytol; 1999; 43(1):81-5. PubMed ID: 9987455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.